KENNEWICK, Wash., April 15, 2025 /PRNewswire/ -- Cadwell Industries, Inc., a global leader in neurodiagnostic, neuromonitoring, and sleep solutions, today...
BEDFORD, Mass., April 15, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization,...
IRVINE, Calif., April 15, 2025 /PRNewswire/ -- Breakthrough Genomics, a California-based leader in AI-driven rare disease diagnostics, announced today a groundbreaking...
Delivering Proven ROI in Smart Hospital Room Technology Across 70+ Health Systems CLEARWATER, Fla., April 15, 2025 /PRNewswire/ -- hellocare.ai, the...
Co-founder Dr. Clément Bars to present on additional TAILORED-AF clinical trial findingsDr. John Hummel to present the initial outcomes of...
Rapidly growing lung health company aims to redefine early diagnosis and precision lung cancer care using multi-modal artificial intelligence (AI)....
Sapiens' solution will accelerate Universal Life's growth and efficiency ROCHELLE PARK, N.J., April 15, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:...
Virtual KOL Event on Wednesday, April 23, 2025, at 2:30 p.m. ET CAMBRIDGE, Mass., April 15, 2025 /PRNewswire/ -- Leap Therapeutics,...
MENLO PARK, Calif., April 15, 2025 /PRNewswire/ -- Subtle Medical, a leading provider of AI-powered solutions for faster and higher-quality...
Toronto, Ontario--(Newsfile Corp. - April 15, 2025) - Specialty Medical Partners, We aim to establish Canada’s most comprehensive outpatient specialty...
The companies are now moving forward with the import permit application process.Following expected approval of the import permit, Red Light...
New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company")...
Dr. Chung brings expertise in scaling medical teams to Ezra’s mission of making early cancer detection accessible to everyone Dr....
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with...
CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
Study Highlights Critical Influence of AI-Driven Reputation on Pharma Market Leaders and New EntrantsCAMPBELL, Calif. and NEW YORK, April 15,...
ELYXYB® is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or...
LOUISVILLE, Ky., April 15, 2025 (GLOBE NEWSWIRE) -- Confluent Health, a nationwide network of physical and occupational therapy companies, recently...
Veteran Oncologist and Clinical Development expert to lead global medical strategy supporting patient-focused drug development and deliveryDURHAM, N.C., April 15,...
The global healthtech market is experiencing rapid growth due to increasing health awareness and preventive care and the surge in...